Co-Diagnostics Inc New (CODX) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Co-diagnostics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.336 Thank you. I'd like to turn the conference over to Andrew Benson, Head of Investor 00:00:05.336 -- 00:00:09.538 Relations. Andrew, please go ahead. 00:00:09.841 -- 00:00:13.905 Good afternoon, everyone. Thank you all for participating in today's conference call. 00:00:13.905 -- 00:00:18.469 On the line today from CoDiagnostics, we have Dwight Egan, Chief Executive Officer, and 00:00:18.469 -- 00:00:23.534 Brian Brown, Chief Financial Officer. Earlier today, CoDiagnostics released financial 00:00:23.534 -- 00:00:27.453 results from the second quarter and in June 30, 2025. 00:00:27.453 -- 00:00:31.359 A copy of the press release is available on the company's website. 00:00:31.359 -- 00:00:35.345 We will begin with management's prepared remarks and then open up the call to analyst 00:00:35.345 -- 00:00:39.631 Q&A. Before we begin, we would like to inform the listeners that certain statements made 00:00:39.631 -- 00:00:43.577 by CoDiagnostics during this call, which are not historical facts or forward-looking 00:00:43.577 -- 00:00:47.743 statements. This includes statements concerning the company's CoDiagnostics PCR testing 00:00:47.743 -- 00:00:53.171 platform, which requires regulatory approval and marketing authorization for diagnostic 00:00:53.171 -- 00:00:58.087 use and is not currently for sale. in addition to diagnostic test developments and timing 00:00:58.087 -- 00:01:03.315 for commencement of clinical evaluations. Actual outcomes and results may differ materially 00:01:03.315 -- 00:01:06.800 from what is expressed or implied in any statement. 00:01:06.800 -- 00:01:11.026 Important factors which could cause actual results to differ materially from those in 00:01:11.026 -- 00:01:15.934 these forward-looking statements are deta...